ConductScience.org, home

Paper24672200

Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study.

Deka P and 5 others. J Midlife Health, 2014. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study. Papers, record 24672200. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24672200

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study.
PubMed
Journal
J Midlife Health
PubMed
Year
2014
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
0.69
iCite
Revised in PubMed
2021-10-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Deka PPankaj
2Barmon DDebabrata
3Shribastava SSushrata
4Kataki ACAmal Chandra
5Sharma JDJ D
6Bhattacharyya MM

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17774836The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients.Gynecol Oncol1995https://conductscience.org/library/papers/7774836PubMed
217161169Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.Int J Gynaecol Obstet2006https://conductscience.org/library/papers/17161169PubMed
320153883Does the number of nodes removed impact survival in vulvar cancer patients with node-negative disease?Gynecol Oncol2010https://conductscience.org/library/papers/20153883PubMed
419331201Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer.Anticancer Res2009https://conductscience.org/library/papers/19331201PubMed
519367689Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium.Int J Gynaecol Obstet2009https://conductscience.org/library/papers/19367689PubMed
62014852Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study).Am J Obstet Gynecol1991https://conductscience.org/library/papers/2014852PubMed
76488136Preoperative radiation therapy for locally advanced vulvar cancer.Cancer1984https://conductscience.org/library/papers/6488136PubMed
83972295Prognostic factors in carcinoma of the vulva.Gynecol Oncol1985https://conductscience.org/library/papers/3972295PubMed
922266935Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment.Int J Gynecol Cancer2012https://conductscience.org/library/papers/22266935PubMed
1011803102Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958-1996.Eur J Obstet Gynecol Reprod Biol2002https://conductscience.org/library/papers/11803102PubMed

Download CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42038989Temporal Trends in Vulvar Cancer Cases and Associated Factors of Adverse Clinical Features: A 6-year Retrospective Study From a Tertiary Hospital in Indonesia.Int J Womens Health2026https://conductscience.org/library/papers/42038989PubMed
41561673Systemic inflammation indices and serum squamous cell carcinoma (SCC) antigen: an exploratory analysis on prognosis of patients with vulvar squamous cell carcinoma.Gynecol Oncol Rep2026https://conductscience.org/library/papers/41561673PubMed
40207260Vascular segmental exclusion for recurrent vulvar squamous cell carcinoma invading the femoral vessels.J Vasc Surg Cases Innov Tech2025https://conductscience.org/library/papers/40207260PubMed
39758564Survival Trends Following Surgical Management in Carcinoma Vulva Patients During Covid 19 Pandemic: A Tertiary Care Hospital Study.J Obstet Gynaecol India2024https://conductscience.org/library/papers/39758564PubMed
39695681Patterns of care for vulvar cancer and insights from revised FIGO staging: a retrospective study.World J Surg Oncol2024https://conductscience.org/library/papers/39695681PubMed
36417690The Unmet Needs in the Management of Vulvar Cancer and a Review of Indian Literature.JCO Glob Oncol2022https://conductscience.org/library/papers/36417690PubMed
34452569Clinicopathological Prognostic Factors Influencing Survival Outcomes of Vulvar Cancer.Asian Pac J Cancer Prev2021https://conductscience.org/library/papers/34452569PubMed
31844370An Overview of Vulvar Cancer: A Single-Center Study from Northeast India.J Obstet Gynaecol India2019https://conductscience.org/library/papers/31844370PubMed
25930015Vulvar cancer: a review for dermatologists.Wien Med Wochenschr2015https://conductscience.org/library/papers/25930015PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24672200

GET https://conductscience.org/api/papers/v1/24672200/authors